Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 15, Issue 5, Pages 311-325Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrd.2015.13
Keywords
-
Funding
- Associazione Italiana per la Ricerca sul Cancro (AIRC)
Ask authors/readers for more resources
The conversion of cells with an epithelial phenotype into cells with a mesenchymal phenotype, referred to as epithelial-mesenchymal transition, is a critical process for embryonic development that also occurs in adult life, particularly during tumour progression. Tumour cells undergoing epithelial-mesenchymal transition acquire the capacity to disarm the body's antitumour defences, resist apoptosis and anticancer drugs, disseminate throughout the organism, and act as a reservoir that replenishes and expands the tumour cell population. Epithelial-mesenchymal transition is therefore becoming a target of prime interest for anticancer therapy. Here, we discuss the screening and classification of compounds that affect epithelial-mesenchymal transition, highlight some compounds of particular interest, and address issues related to their clinical application.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available